Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13334
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJohnston, Colin Ien
dc.contributor.authorFabris, Brunoen
dc.contributor.authorJandeleit, Ken
dc.date.accessioned2015-05-16T03:09:59Z
dc.date.available2015-05-16T03:09:59Z
dc.date.issued1993-07-01en
dc.identifier.citationKidney International. Supplement; 42(): S59-63en
dc.identifier.govdoc8361131en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/13334en
dc.description.abstractIt has now been demonstrated by several techniques that all components of the renin-angiotensin system reside within the kidney. It is likely that angiotensin II is formed within interstitial renal tissue, as well as intracellularly, and acts locally in an autocrine, paracrine or intracrine manner. It has been difficult to dissect the different renal physiological roles of circulating angiotensin II as opposed to intrarenal generated angiotensin II. Angiotensin converting enzyme (ACE) inhibitors have played an important role in helping distinguish the effects of intrarenal angiotensin. Apart from hemodynamic actions and effects on glomerular filtration rate and renal tubular function, the intrarenal renin angiotensin system probably plays an important role as a regulator of renal sympathetic activity, modifies mesangial cell function, acts as a renal growth promoter, maintains endothelial cell function, and may be an important inflammatory mediator in the kidney. The renoprotective action of ACE inhibitors in reducing proteinuria and in slowing the fall in glomerular filtration rate in experimental and human renal disease may involve any of the above mechanisms. However, a prerequisite for the renoprotective action of ACE inhibitors is reduction of systemic blood pressure.en
dc.language.isoenen
dc.subject.otherAngiotensin-Converting Enzyme Inhibitors.pharmacologyen
dc.subject.otherAnimalsen
dc.subject.otherHumansen
dc.subject.otherKidney.drug effects.physiology.physiopathologyen
dc.subject.otherKidney Failure, Chronic.drug therapyen
dc.subject.otherProteinuria.drug therapyen
dc.subject.otherRenin-Angiotensin System.physiologyen
dc.titleIntrarenal renin-angiotensin system in renal physiology and pathophysiology.en
dc.typeJournal Articleen
dc.identifier.journaltitleKidney International. Supplementen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne Austin Hospital, Heidelberg, Victoria, Australiaen
dc.description.pagesS59-63en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/8361131en
dc.type.austinJournal Articleen
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
Appears in Collections:Journal articles
Show simple item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.